Skip to main content

Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center

This is a preview of subscription content, access via your institution.

References

  1. Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas D, Martelletti P (2019) European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain 20:6

    Article  Google Scholar 

  2. Barbanti P, Aurilia C, Egeo G, Fofi L (2019) Erenumab: from scientific evidence to clinical practice—the first Italian real-life data. Neurol Sci 40(1):177–179

    Article  Google Scholar 

  3. Ornello R, Casalena A, Frattale I et al (2020) Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy. J Headache Pain 21(1)

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sabina Cevoli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants including the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Matteo, E., Favoni, V., Pascazio, A. et al. Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center. Neurol Sci 41, 483–484 (2020). https://doi.org/10.1007/s10072-020-04667-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04667-0